Brenna C. Simons

1.1k total citations
33 papers, 773 citations indexed

About

Brenna C. Simons is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Brenna C. Simons has authored 33 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 18 papers in Hepatology and 10 papers in Immunology. Recurrent topics in Brenna C. Simons's work include Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (17 papers) and Liver Disease Diagnosis and Treatment (15 papers). Brenna C. Simons is often cited by papers focused on Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (17 papers) and Liver Disease Diagnosis and Treatment (15 papers). Brenna C. Simons collaborates with scholars based in United States, Germany and Denmark. Brenna C. Simons's co-authors include Brian J. McMahon, Andrea E. Edling, Bryan Williams, Rhonda K. Oates, Michael DeVeer, Daniel J. Lindner, Mark Whitmore, Philip R. Spradling, Chriss Homan and Susan Negus and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Brenna C. Simons

32 papers receiving 753 citations

Peers

Brenna C. Simons
Nikolaus Jilg United States
Ana C. Tuyama United States
Qing Guo China
S Iino Japan
Han Ma United States
Narayan Ramamurthy United Kingdom
Nikolaus Jilg United States
Brenna C. Simons
Citations per year, relative to Brenna C. Simons Brenna C. Simons (= 1×) peers Nikolaus Jilg

Countries citing papers authored by Brenna C. Simons

Since Specialization
Citations

This map shows the geographic impact of Brenna C. Simons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenna C. Simons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenna C. Simons more than expected).

Fields of papers citing papers by Brenna C. Simons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brenna C. Simons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenna C. Simons. The network helps show where Brenna C. Simons may publish in the future.

Co-authorship network of co-authors of Brenna C. Simons

This figure shows the co-authorship network connecting the top 25 collaborators of Brenna C. Simons. A scholar is included among the top collaborators of Brenna C. Simons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenna C. Simons. Brenna C. Simons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Bianca, Karen Miernyk, Jonathan Steinberg, et al.. (2024). Haemophilus influenzae Type b Vaccine Immunogenicity in American Indian/Alaska Native Infants. PEDIATRICS. 154(4). 1 indexed citations
2.
Cella, Eleonora, Catherine G. Sutcliffe, Lindsay R. Grant, et al.. (2024). Streptococcus pneumoniae serotype 3 population structure in the era of conjugate vaccines, 2001–2018. Microbial Genomics. 10(3). 2 indexed citations
3.
Bruden, Dana, Brian J. McMahon, Mary Snowball, et al.. (2023). Rate and durability of the clearance of HBsAg in Alaska Native persons with long-term HBV infection: 1982–2019. Hepatology. 79(6). 1412–1420. 3 indexed citations
4.
Bruce, Michael G., Dana Bruden, Debby Hurlburt, et al.. (2022). Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose. Hepatology. 76(4). 1180–1189. 31 indexed citations
5.
Townshend‐Bulson, Lisa, Dana Bruden, Chriss Homan, et al.. (2021). The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals. PLoS ONE. 16(12). e0260970–e0260970. 2 indexed citations
7.
Shah, Pir Ahmad, et al.. (2020). Patterns of HBeAg and HBsAg clearance among a treatment‐naive Alaskan Cohort in a long‐term observational study. Journal of Viral Hepatitis. 27(6). 644–646. 1 indexed citations
8.
McMahon, Brian J., Lisa Townshend‐Bulson, Chriss Homan, et al.. (2019). Cascade of Care for Alaska Native People With Chronic Hepatitis C Virus Infection: Statewide Program With High Linkage to Care. Clinical Infectious Diseases. 70(9). 2005–2007. 12 indexed citations
9.
Bouckaert, Remco, Brenna C. Simons, Henrik Krarup, T. Max Friesen, & Carla Osiowy. (2017). Tracing hepatitis B virus (HBV) genotype B5 (formerly B6) evolutionary history in the circumpolar Arctic through phylogeographic modelling. PeerJ. 5. e3757–e3757. 5 indexed citations
10.
Gounder, Prabhu, Dana Bruden, Lisa Townshend‐Bulson, et al.. (2016). Does Incorporating Change in APRI or FIB-4 Indices Over Time Improve the Accuracy of a Single Index for Identifying Liver Fibrosis in Persons With Chronic Hepatitis C Virus Infection?. Journal of Clinical Gastroenterology. 52(1). 60–66. 6 indexed citations
11.
McMahon, Brian J., Dana Bruden, Lisa Townshend‐Bulson, et al.. (2016). Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death. Clinical Gastroenterology and Hepatology. 15(3). 431–437.e2. 42 indexed citations
12.
Livingston, Stephen, Lisa Townshend‐Bulson, Dana Bruden, et al.. (2016). Results of interferon-based treatments in Alaska Native and American Indian population with chronic hepatitis C. International Journal of Circumpolar Health. 75(1). 30696–30696. 8 indexed citations
13.
McMahon, Brian J., L. R. Bulkow, Prabhu Gounder, et al.. (2015). Impact of Programs to Manage Alaska Native Patients with Chronic Hepatitis B and C in Urban and Remote Rural Areas using a Data Base Registry.. International Journal of Epidemiology. 44(suppl_1). i57–i58. 1 indexed citations
14.
Spradling, Philip R., Lisa Bulkow, Eyasu H. Teshale, et al.. (2014). Prevalence and causes of elevated serum aminotransferase levels in a population-based cohort of persons with chronic hepatitis B virus infection. Journal of Hepatology. 61(4). 785–791. 38 indexed citations
15.
McMahon, Brian J., Lisa Bulkow, Brenna C. Simons, et al.. (2013). Relationship Between Level of Hepatitis B Virus DNA and Liver Disease: A Population-based Study of Hepatitis B e Antigen–Negative Persons With Hepatitis B. Clinical Gastroenterology and Hepatology. 12(4). 701–706.e3. 20 indexed citations
16.
Kowalec, Kaarina, G. Y. Minuk, Malene Landbo Børresen, et al.. (2012). Genetic diversity of hepatitis B virus genotypes B6, D and F among circumpolar indigenous individuals. Journal of Viral Hepatitis. 20(2). 122–130. 27 indexed citations
17.
Simons, Brenna C. & Spyros A. Kalams. (2007). The potential role of epitope-specific T-cell receptor diversity in the control of HIV replication. Current Opinion in HIV and AIDS. 2(3). 177–182. 1 indexed citations
18.
Meyer‐Olson, Dirk, Kristin O’Sullivan, Brenna C. Simons, et al.. (2005). Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire. Blood. 107(6). 2373–2383. 45 indexed citations
19.
Ni, Jing, Xingqiao Wen, Jorge L. Yao, et al.. (2005). Tocopherol-Associated Protein Suppresses Prostate Cancer Cell Growth by Inhibition of the Phosphoinositide 3-Kinase Pathway. Cancer Research. 65(21). 9807–9816. 80 indexed citations
20.
Whitmore, Mark, Michael DeVeer, Andrea E. Edling, et al.. (2004). Synergistic Activation of Innate Immunity by Double-Stranded RNA and CpG DNA Promotes Enhanced Antitumor Activity. Cancer Research. 64(16). 5850–5860. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026